NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 24 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,023 | -2.5% | 412,743 | 0.0% | 0.00% | – |
| Q2 2023 | $37,972 | +512.6% | 412,743 | +1631.1% | 0.00% | – |
| Q1 2023 | $6,199 | -38.1% | 23,843 | -50.0% | 0.00% | – |
| Q4 2022 | $10,014 | +66.9% | 47,686 | +100.0% | 0.00% | – |
| Q3 2022 | $6,000 | -64.7% | 23,843 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -10.5% | 23,843 | 0.0% | 0.00% | – |
| Q1 2022 | $19,000 | -20.8% | 23,843 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | -42.9% | 23,843 | 0.0% | 0.00% | – |
| Q3 2021 | $42,000 | -4.5% | 23,843 | 0.0% | 0.00% | – |
| Q2 2021 | $44,000 | – | 23,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 36,838 | $26,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,440 | $74,000 | 0.00% |
| PDS Planning, Inc | 10,565 | $8,000 | 0.00% |
| UBS Group AG | 105 | $0 | 0.00% |
| Parallel Advisors, LLC | 350 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,722 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,954 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 39,414 | $28,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 227,452 | $164,000 | 0.00% |